Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Fibromyalgia: Prevalence, epidemiologic profiles and economic costs
Journal Information
Vol. 149. Issue 10.
Pages 441-448 (November 2017)
Share
Share
Download PDF
More article options
Visits
12
Vol. 149. Issue 10.
Pages 441-448 (November 2017)
Review
Fibromyalgia: Prevalence, epidemiologic profiles and economic costs
Fibromialgia: prevalencia, perfiles epidemiológicos y costes económicos
Visits
12
Asensi Cabo-Meseguera,
Corresponding author
asensicabo@hotmail.com

Corresponding author.
, Germán Cerdá-Olmedob, José Luis Trillo-Matac
a Escuela de Doctorado, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain
b Facultad de Medicina, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain
c Departamento Clínico Malvarrosa, Conselleria de Sanidad, Generalitat Valenciana, Valencia, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (4)
Show moreShow less
Tables (2)
Table 1. Prevalence of FM in the world.
Table 2. FM costs in Spain and the Valencian Community.
Show moreShow less
Abstract

Fibromyalgia is an idiopathic chronic condition that causes widespread musculoskeletal pain, hyperalgesia and allodynia. This review aims to approach the general epidemiology of fibromyalgia according to the most recent published studies, identifying the general worldwide prevalence of the disease, its basic epidemiological profiles and its economic costs, with specific interest in the Spanish and Comunidad Valenciana cases.

Fibromyalgia affects, on average, 2.10% of the world's population; 2.31% of the European population; 2.40% of the Spanish population; and 3.69% of the population in the Comunidad Valenciana. It supposes a painful loss of the quality of life of the people who suffer it and the economic costs are enormous: in Spain is has been estimated at more than 12,993 million euros annually.

Keywords:
Fibromyalgia
Epidemiology
Prevalence
Economic impact
Resumen

La fibromialgia es una enfermedad crónica idiopática que ocasiona dolor musculoesquelético generalizado, hiperalgesia y alodinia. La presente revisión pretende aproximarse a la epidemiología general de la fibromialgia de acuerdo con los más recientes estudios publicados, identificar la prevalencia general de la enfermedad a nivel mundial, sus perfiles epidemiológicos básicos y los costes económicos que ocasiona, con interés específico en el caso de España y de la Comunidad Valenciana.

La fibromialgia afecta como promedio a un 2,10% de la población mundial; al 2,31% de la europea; al 2,40% en la población española y al 3,69% de la población en la Comunidad Autónoma Valenciana. Supone una dolorosa pérdida de la calidad de vida de las personas que la presentan y los costes económicos son enormes: en el caso español se han estimado en más de 12.993 millones de euros anuales.

Palabras clave:
Fibromialgia
Epidemiología
Prevalencia
Impacto económico

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos